Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia (2023)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; RIBEIRO, DEIDIANE ELISA - IQ
- Unidade: IQ
- Subjects: ANTIOXIDANTES; ESQUIZOFRENIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Biociências Nucleares/SBBN
- Publisher place: São Paulo
- Date published: 2023
- Source:
- Conference titles: Reunião Anual da Federação de Sociedade de Biologia Experimental/FeSBE
-
ABNT
TOSCANO, Luis Felipe et al. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia. 2023, Anais.. São Paulo: Sociedade Brasileira de Biociências Nucleares/SBBN, 2023. Disponível em: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br. Acesso em: 27 dez. 2025. -
APA
Toscano, L. F., Vargas, L., Bezerra, T., Ribeiro, D. E., Ulrich, H., & Salum, C. O. R. (2023). Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia. In Anais. São Paulo: Sociedade Brasileira de Biociências Nucleares/SBBN. Recuperado de https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br -
NLM
Toscano LF, Vargas L, Bezerra T, Ribeiro DE, Ulrich H, Salum COR. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia [Internet]. Anais. 2023 ;[citado 2025 dez. 27 ] Available from: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br -
Vancouver
Toscano LF, Vargas L, Bezerra T, Ribeiro DE, Ulrich H, Salum COR. Effect of treatment with the antioxidant N-acetyl-l-cysteine or the purinergic antagonist (BBG) in the mam model of schizophrenia [Internet]. Anais. 2023 ;[citado 2025 dez. 27 ] Available from: https://proceedings.science/fesbe-2023/trabalhos?lang=pt-br - Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease
- Preclinical studies of P2X receptors in depression-related behaviours and antidepressant effects
- Inibição da síntese de óxido nítrico efeito tipo-panicolítico em animais: possível participação de BDNF E TRKB na substância cinzenta periquedutal dorsal
- Coronavírus no cérebro: Drogas que bloqueiam receptor poderiam prevenir ou tratar problemas neurológicos [Depoimento a Luiza Caires]
- Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease
- P2X7 receptor signaling in stress and depression
- The P2X7 receptor: central hub of brain diseases
- Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases
- Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- Antagonistic roles of P2X7 and P2Y2 receptors in neurodegenerative diseases
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
